COVID-19 lung disease: Lessons Learned, An Issue of Clinics in Chest Medicine

1st Edition, Volume 44-2 - April 21, 2023
Editors: Charles S. Dela Cruz, Guang-Shing Cheng
Language: English
Hardback ISBN:
9 7 8 - 0 - 3 2 3 - 9 6 1 7 7 - 6
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 6 1 7 8 - 3

In this issue of Clinics in Chest Medicine, guest editors Drs. Drew Harris, Emily Brigham, and Juan Celedon bring their considerable expertise to the topic of Aiming to Improve… Read more

COVID-19 lung disease: Lessons Learned, An Issue of Clinics in Chest Medicine

Purchase options

Info / Buy

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Request a sales quote

In this issue of Clinics in Chest Medicine, guest editors Drs. Drew Harris, Emily Brigham, and Juan Celedon bring their considerable expertise to the topic of Aiming to Improve Equity in Pulmonary Health. Top experts discuss disparities in risk factors for respiratory diseases, how communities are affected unequally, interventions to mitigate disparities, and evidence of effects, if present.

Cover image
Title page
Table of Contents
Copyright
Contributors
Forthcoming Issues
Preface
What Have We Learned About Transmission of Coronavirus Disease-2019: Implications for Pulmonary Function Testing and Pulmonary Procedures
Key points
Introduction
Summary
Clinics care points
Disclosure
Funding sources
Coronavirus Disease-2019 Pneumonia: Clinical Manifestations
Key points
Introduction
Risk factors
Clinical course
Radiographic findings
Lessons learned
Clinics care points
Pathophysiology of Hypoxemia in COVID-19 Lung Disease
Key points
Introduction
Summary
Clinics care points
Disclosure
Impact of COVID-19 on Nonpulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes
Key points
Introduction
Summary
Clinics care points
Disclosure
Post-COVID Interstitial Lung Disease and Other Lung Sequelae
Key points
Introduction
Post-COVID lung disease
Summary
Clinics care points
Disclosure
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
Key points
Introduction
Direct antiviral agents
Monoclonal antibodies
Other therapies for treatment of coronavirus disease-2019
Management of outpatient coronavirus disease-2019 and preexposure prophylaxis
Management of inpatient coronavirus disease-2019
Impact of severe acute respiratory syndrome coronavirus 2 variants on treatment
Summary
Clinics care points
Disclosure
Appendix
Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia
Key points
Introduction
Summary
Clinics care points
Disclosure
Lessons Learned in Mechanical Ventilation/Oxygen Support in Coronavirus Disease 2019
Key points
Background
Search strategy
Discussion
Potential rescue therapies and other considerations
Summary
Clinics care points
Disclosure
The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned
Key points
Introduction
Clinical care
Surge capacity and extracorporeal membrane oxygenation
Development of new extracorporeal membrane oxygenation centers
Evaluating effectiveness of extracorporeal membrane oxygenation in an ongoing pandemic
Summary
Clinics care points
Disclosure
Lung Transplantation in Coronavirus-19 Patients: What We Have Learned So Far
Key points
Introduction
Nature of the problem
Case report
Preoperative lung transplant evaluation
Operative approach
Postoperative management
Outcomes
Future directions
Summary
Clinics care points
Disclosure
SARS-CoV-2 Infection and COVID-19 in Children
Key points
Epidemiology
Risk factors for severe disease
Clinical manifestations
Multisystem inflammatory syndrome in children
Summary
Clinics care points
Financial disclosures
Coronavirus Disease-2019 in Pregnancy
Key points
Introduction
Clinical relevance
Evaluation
Therapeutic options
Prevention
Summary
Clinics care points
Disclosure
COVID-19 in Patients with Chronic Lung Disease
Key points
Mechanisms of severe acute respiratory syndrome coronavirus 2 infection in the lung
Asthma
Chronic obstructive pulmonary disease
Bronchiectasis
Cystic fibrosis
Interstitial lung disease
Pulmonary arterial hypertension
Summary
Clinics care points
Disclosure
Coronavirus Disease-2019 in the Immunocompromised Host
Key points
Introduction
Mechanisms of immunocompromise
Treatment
Vaccination
Summary
Clinics care points
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
Key points
Introduction
Epidemiologic trends of common respiratory viruses during the severe acute respiratory syndrome coronavirus 2 pandemic
Epidemiologic trends of other respiratory viruses
Impact of social distancing and vaccination on the spread of common respiratory viral infections during the coronavirus disease 2019 pandemic
Severe acute respiratory syndrome coronavirus 2 and viral coinfections
Severe acute respiratory syndrome coronavirus 2, bacterial coinfections, and superinfections
Severe acute respiratory syndrome coronavirus 2 and community-acquired pneumonia
Coronavirus disease 2019 and ventilator-associated pneumonia
Coronavirus disease 2019 and other nosocomial infections
Coronavirus disease 2019 and invasive fungal infections
Summary
Clinics care points
Disclosure
Lessons Learned from Health Disparities in Coronavirus Disease-2019 in the United States
Key points
Introduction
Summary
Funding/support
Disclosure
Lessons Learned from a Global Perspective of Coronavirus Disease-2019
Key points
Introduction
Non-pharmacological measures
Impact on health care and resource allocation
Literature in coronavirus disease and research efforts
Vaccination
Socioeconomic impact
The path forward
Conflicts of interest and disclosure statement

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health

COVID-19 lung disease: Lessons Learned, An Issue of Clinics in Chest Medicine

Purchase options

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Charles S. Dela Cruz

Guang-Shing Cheng